Aurobindo Pharma, CVC Capital jointly bid for Merck's generics ops - report |
|
|
|
Published
:
Thu, 22 Mar 2007 11:58
|
MUMBAI (AFX) - India's mid-sized drug maker Aurobindo Pharma Ltd, has tied up with private equity fund CVC Capital Partners (Deutschland) GmbH to bid for Merck KGaA's global generics business, reported the daily Mint, citing people familiar with the bids.CVC Capital Partners will extend manufacturing and management support in the event that Aurobindo Pharma emerges the winner for the generics operations, the article said.Both Aurobindo and CVC Capital Partners declined to comment to the newspaper.Other Indian companies, Dr Reddys Laboratories and Ranbaxy Laboratories Ltd, had pulled out of the bidding process over price issues, while Cipla Ltd, which had tied up with a private equity consortium for the bid, is no longer a contender, the report said.newsdesk@afxnews.comrba/ra/cmrCOPYRIGHTCopyright AFX News Limited 2007. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited
|
|
|
|
Print this Story
India's Dr Reddy's may join race for generics ops of Germany's Merck - report 